At Recor Medical, we are pioneering Ultrasound Renal Denervation (uRDN) therapy to treat hypertension, the leading cardiovascular risk factor in the world. With our Paradise™ uRDN System, we’re on a mission to provide the millions of people who suffer from hypertension with a non-drug and minimally invasive option to lower their blood pressure. Join us on our journey and make a meaningful impact on the lives of people around the globe.
Position Summary
The Director of Intellectual Property will be a key member of Recor’s Intellectual Property Team. The Intellectual Property Department provides centralized legal services and support for Recor Medical and its affiliates and subsidiaries worldwide. This individual will report to Recor Medical’s Head of Intellectual Property with minimal supervision and will be accountable for results impacting both the IP department, and the company as a whole. They will work in close collaboration with colleagues from both Recor’s and OMD’s Intellectual Property departments. They will creatively and effectively apply their broad understanding of international patent prosecution procedures, global patent law, intellectual property due diligence, and IP transactions to build a world-class patent portfolio. They will have a proven track record of quicky coming up to speed with challenging technology to become recognized as a subject matter expert. The Director will work across departments to contribute to the development of Recor’s objectives and priorities in innovation. The main focus of this position will be to assist in building Recor Medical’s patent portfolio by capturing detailed invention disclosures, differentiating prior art, preparing patent applications, and responding to office actions.
COVID-19 vaccination requirements
At Recor Medical, we care, we collaborate, we challenge, and we create. Pursuant to these core values, we are focused on the health and safety of our employees, as well as the teamwork essential for innovation of our pioneering technology. COVID-19 vaccines will be required for all ReCor US office employees effective June 10, 2021, as well as all new US office employees joining our company. Fully vaccinated persons are those who are >=14 days post-completion of the primary series of an FDA-authorized COVID-19 vaccine.
Equal Employment Opportunity
At Recor Medical, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
ReCor Medical Applicant Privacy Policy (linked)
Subscribe to Rise newsletter